Evidence map›Paper›PMID 40077695›Full record

ArticleNutrients2025

Microbiome-Based Therapeutics for Salt-Sensitive Hypertension: A Scoping Review.

Abdulwhab Shremo Msdi, Anahita Haghparast, Kevin W Garey, Elisabeth M Wang

Abstract readScoping Review
In one paragraph

Article in Nutrients, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Review
  2. Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Abdulwhab Shremo MsdiDepartment of Pharmacy Practice and Translational Research, College of Pharmacy, University of Houston, 4349 Martin Luther King Boulevard, Houston, TX 77204, USA.ORCID 0009-0009-1582-0611
Anahita HaghparastDepartment of Pharmacy Practice and Translational Research, College of Pharmacy, University of Houston, 4349 Martin Luther King Boulevard, Houston, TX 77204, USA.
Kevin W GareyDepartment of Pharmacy Practice and Translational Research, College of Pharmacy, University of Houston, 4349 Martin Luther King Boulevard, Houston, TX 77204, USA.ORCID 0000-0003-2063-7503
Elisabeth M WangDepartment of Pharmacy Practice and Translational Research, College of Pharmacy, University of Houston, 4349 Martin Luther King Boulevard, Houston, TX 77204, USA.ORCID 0000-0002-5655-5318

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The purpose of this scoping review was to provide a comprehensive understanding of the current knowledge concerning the gut microbiome and SCFAs as emerging treatments for salt-sensitive hypertension. Relevant animal and human studies were identified via PubMed through August 2024. Twenty-four human (

Indexed as

Gastrointestinal MicrobiomeHypertensionSodium Chloride, DietaryAnimalsBlood PressureDiet, Sodium-RestrictedHumansMicePrebioticsProbioticsRatsPrebioticsSodium Chloride, Dietarycardiovascular diseaselive biotherapeutic productsmicrobiotapostbioticsprebioticsprobiotics

Identifiers

PMID40077695
PMCPMC11901721

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.